1. Home
  2. CYTK vs SMAR Comparison

CYTK vs SMAR Comparison

Compare CYTK & SMAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • SMAR
  • Stock Information
  • Founded
  • CYTK 1997
  • SMAR 2005
  • Country
  • CYTK United States
  • SMAR United States
  • Employees
  • CYTK N/A
  • SMAR N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • SMAR Computer Software: Prepackaged Software
  • Sector
  • CYTK Health Care
  • SMAR Technology
  • Exchange
  • CYTK Nasdaq
  • SMAR Nasdaq
  • Market Cap
  • CYTK 5.7B
  • SMAR 6.9B
  • IPO Year
  • CYTK 2004
  • SMAR 2018
  • Fundamental
  • Price
  • CYTK $47.09
  • SMAR $56.04
  • Analyst Decision
  • CYTK Buy
  • SMAR Hold
  • Analyst Count
  • CYTK 16
  • SMAR 23
  • Target Price
  • CYTK $84.07
  • SMAR $55.28
  • AVG Volume (30 Days)
  • CYTK 1.1M
  • SMAR 2.7M
  • Earning Date
  • CYTK 11-06-2024
  • SMAR 12-05-2024
  • Dividend Yield
  • CYTK N/A
  • SMAR N/A
  • EPS Growth
  • CYTK N/A
  • SMAR N/A
  • EPS
  • CYTK N/A
  • SMAR N/A
  • Revenue
  • CYTK $3,219,000.00
  • SMAR $1,083,216,000.00
  • Revenue This Year
  • CYTK N/A
  • SMAR $19.27
  • Revenue Next Year
  • CYTK $706.87
  • SMAR $15.05
  • P/E Ratio
  • CYTK N/A
  • SMAR N/A
  • Revenue Growth
  • CYTK N/A
  • SMAR 18.55
  • 52 Week Low
  • CYTK $45.66
  • SMAR $35.52
  • 52 Week High
  • CYTK $110.25
  • SMAR $56.55
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 37.87
  • SMAR 53.83
  • Support Level
  • CYTK $45.66
  • SMAR $55.96
  • Resistance Level
  • CYTK $50.32
  • SMAR $56.07
  • Average True Range (ATR)
  • CYTK 1.66
  • SMAR 0.11
  • MACD
  • CYTK -0.05
  • SMAR -0.02
  • Stochastic Oscillator
  • CYTK 23.57
  • SMAR 56.41

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SMAR Smartsheet Inc.

Smartsheet is a provider of collaborative work management software delivered via a cloud-based, software-as-a-service model. The firm's solution offers scalable, dynamic tools to improve the efficiency of project and process management across countless use cases. Smartsheet's offering supports workflow management across teams, provides real-time visibility into projects, and reporting and automation capabilities. The firm generates revenue via software subscriptions on a per-user basis, and incremental charges for added platform capabilities.

Share on Social Networks: